Therefore, this preliminary analysis of the association between ESR1, ESR2, and PGR and immune function highlights the importance of future research to elucidate the potential roles of ESR1, ESR2, and PGR as predictive and prognostic biomarkers as well as therapeutic targets for immunotherapy across multiple cancer types. The gene discussed is PGR; the disease is cancer.